Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Such a vaccine would make inoculation easier in developing nations, where the need is great.
The World Health Organization has set various benchmarks for nations to hit in controlling their epidemics by 2030.
The nation has provided unrestricted access to hepatitis C treatment since 2016.
Researchers conducted an analysis of hep C treatment outcomes in those also living with HIV in Western nations.
Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.
Researchers followed a group of teenagers over time and found that their rate of non-alcoholic fatty liver disease rose in young adulthood.
This finding is from a program that sought to provide blanket treatment to Iceland’s hep C population.
Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.
Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.
A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.
Nearly all those who have completed follow-up in an ongoing Italian study have been cured.
HIV-positive men who have sex with men in Western nations historically have a significant risk of contracting hepatitis C through sex.
In particular, having a high hep B viral load increases the risk of women with HIV transmitting the latter virus to their newborns.
This finding stresses the need to reduce the risk of sexual transmission of hep C among HIV-positive men who have sex with men.
A recent study tested the effectiveness and tolerability of Technivie (ombitasvir/paritaprevir/ritonavir) among those over 65.
Doctors are finding ways to diagnose and treat this difficult-to-reach demographic.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.